- •Acknowledgments
- •ANATOMIC CONSIDERATIONS
- •PATIENT MOVEMENT
- •RETROBULBAR HEMORRHAGE
- •TREATMENT AND PREVENTION
- •SUBCONJUNCTIVAL HEMORRHAGE
- •OCULOCARDIAC REFLEX
- •FACIAL NERVE BLOCK
- •CORNEAL EXPOSURE
- •ATONIC PUPIL
- •CONCLUSION
- •2 TOPICAL ANESTHESIA
- •TOPICAL DROP
- •PINPOINT ANESTHESIA (FUKASAKU)
- •TOPICAL GEL ANESTHESIA
- •EYE MOVEMENT
- •VIRTUAL REALITY DEVICE
- •CONJUNCTIVAL BALLOONING
- •INTRACAMERAL TOXICITY
- •TOPICAL TOXICITY
- •PREOPERATIVE EVALUATION
- •CONCLUSION
- •SUTURELESS CATARACT SURGERY
- •THE SCLEROCORNEAL INCISION
- •WOUND CONSTRUCTION PROBLEMS
- •SCLEROCORNEAL (FROWN)
- •CLEAR CORNEA
- •SCLEROCORNEA AND CLEAR CORNEA
- •DESCEMET’S DETACHMENT
- •WOUND BURN
- •WOUND GAPE REPAIR
- •SLIDING FLAP TECHNIQUE
- •PATCH GRAFT TECHNIQUE
- •5 CAPSULORRHEXIS COMPLICATIONS
- •CAPSULAR ANATOMY
- •CAPSULORRHEXIS SIZE
- •CATARACT SIZE AND TYPE
- •IOL OPTIC SIZE
- •ANTERIOR CAPSULAR TEARS
- •NONCONTINUOUS CAPSULORRHEXIS
- •IOL SELECTION
- •ZONULAR DIALYSIS
- •YAG CAPSULOTOMY
- •IRIS STRETCH—TWO INSTRUMENTS
- •SILICONE PUPIL EXPANDER
- •MULTIPLE SPHINCTEROTOMIES
- •IRIS PROLAPSE
- •PHACOEMULSIFICATION
- •IRIDODIALYSIS
- •IRRIGATION AND ASPIRATION
- •ANATOMY
- •HYDRODISSECTION
- •HYDRODELINEATION
- •COMPLICATIONS
- •NONCONTINUOUS CAPSULORRHEXIS
- •CONCLUSION
- •REFERENCES
- •REGIONAL ANESTHESIA
- •FLUID DYNAMICS
- •ETIOLOGY
- •CHOROIDAL VASCULAR FRAGILITY
- •PREVENTIVE MEASURES
- •INTRAOPERATIVE DIAGNOSIS
- •MANAGEMENT OF AISH
- •EXPULSIVE HEMORRHAGE
- •LENS CONSISTENCY
- •REFERENCES
- •HYDRODISSECTION
- •MANUAL DISSECTION
- •12 CHOO CHOO CHOP AND FLIP
- •TECHNIQUE
- •INCOMPLETE CHOPS
- •13 PHACO CHOP
- •CONTRAINDICATIONS
- •MATURE CATARACT
- •CONCLUSION
- •REFERENCES
- •SURGICAL TECHNIQUE
- •COMPLICATIONS
- •INCOMPLETE HYDRODISSECTION
- •CONCLUSION
- •REFERENCES
- •PATIENT EVALUATION
- •VITREOUS MANAGEMENT
- •CONVERSION TO ECCE
- •CONTINUED PHACOEMULSIFICATION
- •CONCLUSION
- •REFERENCES
- •THE INFUSION/ASPIRATION BALANCE
- •CAPSULAR TEARS
- •MAKING A NEW INCISION
- •POSTOPERATIVE CARE
- •LENS MATERIAL AND POSITION
- •CONCLUSION
- •OPERATIVE OCULAR COMPLICATIONS
- •OPERATIVE IOL COMPLICATIONS
- •PHAKIC IOL
- •POSTOPERATIVE IOL COMPLICATIONS
- •IOL REPOSITIONING
- •IOL REMOVAL
- •IOL REPLACEMENT
- •ANATOMIC CONSIDERATIONS
- •PREPARING THE PROXIMAL HAPTIC
- •INSERTION OF THE IOL
- •COMPLICATIONS OF TS PCLs
- •LENS TILT
- •REFERENCES
- •BULLOUS KERATOPATHY
- •STROMAL CORNEAL SCARRING
- •GUTTATALESS FUCHS’
- •COMPLETE DESCEMET’S DETACHMENT
- •POSTOPERATIVE CORNEAL EDEMA
- •BACKGROUND
- •CONCLUSION
- •POSTOCCLUSION SURGE
- •IMMEDIATELY PREOCCLUSION
- •OCCLUSION
- •POSTOCCLUSION
- •ULTRASONIC COMPLICATIONS
- •CONCLUSION
- •RETAINED LENS FRAGMENTS
- •MANAGEMENT OPTIONS
- •POSTOPERATIVE ENDOPHTHALMITIS
- •DELAYED-ONSET ENDOPHTHALMITIS
- •CONCLUSION
- •VISCOCANALOSTOMY PROCEDURE
- •TRABECULECTOMY PROCEDURE
- •IRIS PROLAPSE
- •NPTS–DEEP SCLERAL FLAP
- •DESCEMET’S DETACHMENT
- •HYPOTONOUS MACULOPATHY
- •NPTS
- •CONCLUSION
- •PATIENT SELECTION AND SCHEDULING
- •THE CLANDESTINE WRAPAROUND
- •WHAT’S IMPORTANT NOW
- •SPECIAL MANEUVERS
- •TOPICAL ANESTHESIA
- •INCISION
- •CAPSULORRHEXIS
- •HYDROSTEPS
- •FOLDABLE IOL INSERTION
- •CONCLUSION
- •SMALL PUPILS
This page intentionally left blank
COMPLICATIONS IN PHACOEMULSIFICATION
AVOIDANCE, RECOGNITION, AND MANAGEMENT
Thieme
This page intentionally left blank
COMPLICATIONS IN PHACOEMULSIFICATION
AVOIDANCE, RECOGNITION, AND MANAGEMENT
Edited by
William J. Fishkind, M.D., F.A.C.S.
Clinical Professor
Department of Ophthalmology
University of Utah
Salt Lake City, Utah
Co-Director
Fishkind & Bakewell Eye Care and Surgery Center
Tucson, Arizona
Thieme
New York • Stuttgart
Thieme NewYork
333 Seventh Avenue
NewYork, NY 10001
Editor: Esther Gumpert
Editorial Assistant: Owen Zurhellen
Director, Production and Manufacturing: Anne Vinnicombe
Production Editor: David R. Stewart
Marketing Director: Phyllis Gold
Sales Manager: Ross Lumpkin
Chief Financial Officer: Peter van Woerden
President: Brian D. Scanlan
Medical Illustrator: Anthony M. Pazos
Cover Designer: Kevin Kall
Compositor: Compset, Inc.
Printer: Sfera International
Library of Congress Cataloging in Publication Data is available from the publisher
Copyright © 2002 by Thieme Medical Publishers, Inc. This book, including all parts thereof, is legally protected by copyright. Any use, exploitation, or commercialization outside the narrow limits set by copyright legislation, without the publisher’s consent, is illegal and liable to prosecution. This applies in particular to photostat reproduction, copying, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.
Important note: Medical knowledge is ever-changing. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy may be required. The authors and editors of the material herein have consulted sources believed to be reliable in their efforts to provide information that is complete and in accord with the standards accepted at the time of publication. However, in view of the possibility of human error by the authors, editors, or publisher of the work herein, or changes in medical knowledge, neither the authors, editors, or publisher, nor any other party who has been involved in the preparation of this work, warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from use of such information. Readers are encouraged to confirm the information contained herein with other sources. For example, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this publication is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs.
Some of the product names, patents, and registered designs referred to in this book are in fact registered trademarks or proprietary names even though specific reference to this fact is not always made in the text. Therefore, the appearance of a name without designation as proprietary is not to be construed as a representation by the publisher that it is in the public domain.
Printed in Italy
5 4 3 2 1
TNY ISBN 0-86577-959-7
GTV ISBN 3-13-124681-2
To colleagues, teachers, and surgeons who collectively participate in the splendid mission of restoring sight to our fellow human beings.
This page intentionally left blank
CONTENTS
PREFACE |
ix |
|
ACKNOWLEDGMENTS |
x |
|
CONTRIBUTORS |
xi |
|
1. |
Injectible Ophthalmic Anesthesia—Kenneth J. Rosenthal |
1 |
2. |
Topical Anesthesia—Kenneth J. Rosenthal |
14 |
3. |
Systemic Complications of Ocular Anesthesia—Marc Leib |
24 |
4.Complications of Wound Construction and Closure—Paul H. Ernest, I. Howard Fine, and
|
William J. Fishkind |
28 |
5. |
Capsulorrhexis Complications—Howard V. Gimbel and Ellen E. Anderson Penno |
36 |
6. |
Iris Problems—Alan S. Crandall |
49 |
7.Complications of the Hydrosteps: How to Recognize and Avoid Them—
|
William J. Fishkind |
56 |
8. |
Positive Pressure—Paul N. Arnold |
63 |
9. |
Phaco Procedures: Overview—William J. Fishkind |
75 |
10. |
Four-Quadrant Divide and Conquer—Stephen H. Johnson |
79 |
11. |
Stop and Chop Phaco—Paul S. Koch |
85 |
12. |
Choo Choo Chop and Flip—I. Howard Fine |
90 |
13. |
Phaco Chop—Kunihiro B. Nagahara |
94 |
14. |
Phaco Flip and Tilt and Tumble—Richard G. Livernois |
100 |
15. |
Management of the Soft Nucleus—William J. Fishkind |
105 |
16. |
Management of the Mature Cataract—Samuel Masket |
109 |
17.Cataract Surgery in the Presence of Compromised Zonules—Robert J. Cionni and
|
Robert H. Osher |
116 |
18. |
Torn Posterior Capsule—Marc A. Michelson |
123 |
19. |
Vitrectomy Following Vitreous Loss—Paul S. Koch |
133 |
vii
viii • CONTENTS
20.Intraocular Lens Power Calculations and Lens Selection Following Vitrectomy—
Jack T. Holladay |
140 |
21. Intraocular Lens Implantation—Harry B. Grabow |
144 |
22.Techniques of Primary and Secondary Transscleral Fixation of Posterior Chamber
|
Intraocular Lenses—Stephen S. Lane and Gary S. Schwartz |
155 |
23. |
Corneal Problems Associated with Phacoemulsification—Randall J. Olson |
166 |
24. |
Using Viscoelastics to Manage Problems in Cataract Surgery—Steve A. Arshinoff |
182 |
25. |
Phacodynamic Links to Complications—Barry Seibel |
194 |
26.Posterior Segment Complications—Leonard Joffe, William E. Smiddy, and
|
Harry W. Flynn, Jr. |
204 |
27. |
Phacotrabeculectomy and Other Glaucoma Procedures—Brock K. Bakewell |
223 |
28. |
Prevention Pearls and Damage Control: Part 1—David M. Dillman |
248 |
29. |
Prevention Pearls and Damage Control: Part 2—Roger F. Steinert |
255 |
30. |
Prevention Pearls and Damage Control: Part 3—Louis D. Nichamin |
260 |
31. |
Prevention Pearls and Damage Control: Part 4—David F. Chang |
271 |
INDEX |
281 |
|
PREFACE
For many years I have taught and attended presentations on phacoemulsification complication management. At each course it appeared that my colleagues and I could never learn enough about this subject. However, there was repeatedly a deficiency in the method of instruction. It was often fragmented. I assumed this was brought about by the very nature of the process of dealing with complications management. The associated shock and surprise when challenged with these mishaps instigates an urgent action strategy rather than an attitude of careful analysis, then action.
I therefore decided to attempt to approach this topic with improved organization and in-depth analysis. My approach is to understand where problems may occur by first envisioning the normal circumstance. Mindful of normal procedures to avoid, then recognize, and finally manage a myriad of potential complications becomes a less overwhelming task.
To accomplish this goal I have invited a number of authors to contribute to this textbook. All are the finest educators that I have had the privilege with which to work. They are accomplished as surgeons,
researchers, and writers. All have given their knowledge altruistically, with their only goal being to improve both the quality of surgery and the likelihood for successful outcomes.
Finally, to assist us in the process of visualizing many theoretical concepts, I have enlisted the assistance of one of the most superb medical illustrators in our field. Through accurate illustrations we have attempted to refine our understanding of the many dilemmas a surgeon might encounter. As an adjunct, we have tried to formulate a more concrete method of understanding some new concepts.
This book reflects the experience of more than 3 years of research and development. It is my fervent desire that the information in this textbook has merit to the reader. If I can help to lessen the impact or improve the surgical outcome in a potentially challenging problem, I have accomplished my desired goal.
I, as well as the authors of this text, am an educator. As such, I place great importance on textbooks of this type. Please read, enjoy, and learn from the ensuing material.
William J. Fishkind, M.D., F.A.C.S.
ix
ACKNOWLEDGMENTS
I would like to thank the many teachers who have instructed me, polishing both my surgical and personal skills. They are mentors such as I. Howard Fine, William Maloney, Randy Olson, Alan Crandall, Manus Kraff, and C. Drew Sanders, who have placed confidence in my knowledge and supported my efforts.
I have been privileged to teach with many exceptional individuals. They are too numerous to name individually. However, all the authors of this text deserve my heartfelt thanks. They have unselfishly taken time from their busy schedules to make exceptional contributions to this text. My partner, Brock K. Bakewell deserves special recognition for his will-
ingness to critique many aspects of the text. Another thank you goes to my office administrator, Beverly Lony, and assistant administrator, Jen Engelbrecht, for helping in a myriad of subtle ways.
Finally, thanks go to Tony Pazos, the medical illustrator of this text. He spent countless hours refining illustrations in an effort to clarify abstract concepts for our collective benefit. He developed a system of overlays to improve the illustration quality. I will miss our regular meetings over the past few years.
William J. Fishkind, M.D., F.A.C.S.
x
CONTRIBUTORS
Paul N. Arnold, M.D., F.A.C.S. |
David M. Dillman, M.D. |
|
|
formerly |
Private Practice |
|
|
Arnold Eye Care Center |
Danville, Illinois |
|
|
Springfield, Missouri |
Paul H. Ernest, M.D. |
|
|
|
|
||
Steve A. Arshinoff, M.D., F.R.C.S.(C.) |
Associate Clinical Professor |
|
|
Clinical Instructor |
Department of Ophthalmology |
|
|
Department of Ophthalmology |
Wayne State University |
|
|
University of Toronto |
Detroit, Michigan |
|
|
York Finch Eye Associates |
I. Howard Fine, M.D. |
|
|
Toronto, Ontario, Canada |
|
||
Clinical Associate Professor |
|
||
|
|
||
Brock K. Bakewell, M.D., F.A.C.S. |
Casey Eye Institute |
|
|
Co-Director |
Department of Ophthalmology |
|
|
Fishkind & Bakewell Eye Care and Surgery Center |
Oregon Health and Science University |
|
|
Tucson, Arizona; |
Portland, Oregon |
|
|
Assistant Clinical Professor |
William J. Fishkind, M.D., F.A.C.S. |
|
|
Department of Ophthalmology |
|
||
Clinical Professor |
|
||
University of Utah |
|
||
Department of Ophthalmology |
|
||
Salt Lake City, Utah |
|
||
University of Utah |
|
||
|
|
||
David F. Chang, M.D. |
Salt Lake City, Utah; |
|
|
Clinical Professor |
Co-Director |
|
|
Department of Ophthalmology |
Fishkind & Bakewell Eye Care and Surgery |
|
|
University of California |
Center |
|
|
San Francisco, California |
Tucson, Arizona |
|
|
Robert J. Cionni, M.D. |
Harry W. Flynn, Jr., M.D. |
|
|
Professor of Ophthalmology |
Professor |
|
|
Cincinnati Eye Institute |
Department of Ophthalmology |
|
|
Cincinnati, Ohio |
University of Miami |
|
|
Alan S. Crandall, M.D. |
Bascom Palmer Eye Institute |
|
|
Miami, Florida |
|
||
Professor of Ophthalmology |
|
||
|
|
||
Vice Chair of Clinical Services |
Howard V. Gimbel, M.D., M.P.H. |
|
|
Department of Ophthalmology and Visual Sciences |
Professor and Chair |
|
|
University of Utah Health Sciences Center |
Department of Ophthalmology |
|
|
John A. Moran Eye Center |
Loma Linda University |
xi |
|
Salt Lake City, Utah |
Loma Linda, California; |
||
|
xii • CONTRIBUTORS
Gimbel Eye Centre
Calgary, Alberta, Canada
Harry B. Grabow, M.D.
Clinical Assistant Professor
Department of Ophthalmology
University of South Florida
Sarasota, Florida
Jack T. Holladay, M.D., M.S.E.E.
Clinical Professor
Department of Ophthalmology
Baylor College of Medicine
Bellaire, Texas
Leonard Joffe, M.D., F.C.S.(S.A.), F.R.C.S.(Edin.)
Clinical Associate Professor
Department of Ophthalmology
University of Arizona
Tucson, Arizona
Stephen H. Johnson, M.D.
Private Practice
Newport Beach, California
Paul S. Koch, M.D.
Koch Eye Associates
Warwick, Rhode Island
Stephen S. Lane, M.D.
Clinical Professor
Department of Ophthalmology
University of Minnesota
Stillwater, Minnesota
Marc Leib, M.D., J.D.
Southern Arizona Anesthesia Services
Tucson, Arizona
Richard G. Livernois, M.D.
Medical Director
The Laser Vision Institute
Tampa, Florida
Samuel Masket, M.D.
Clinical Professor
Department of Ophthalmology
UCLA Center for Health Sciences
Los Angeles, California
Marc A. Michelson, M.D.
Assistant Clinical Professor
University of Alabama;
Private Practice
Birmingham, Alabama
Kunihiro B. Nagahara, M.D.
Santa Maria Eye Clinic
Sakaide City, Kagawa, Japan
Louis D. Nichamin, M.D.
Medical Director
Laurel Eye Clinic
Brookville, Pennsylvania
Randall J. Olson, M.D.
John A. Moran Presidential Professor
Chair and Director of the John A. Moran Eye Center Department of Ophthalmology
University of Utah Health Sciences Center Salt Lake City, Utah
Robert H. Osher, M.D.
Medical Director
Cincinnati Eye Institute;
Professor
Department of Ophthalmology
University of Cincinnati College of Medicine
Cincinnati, Ohio
Ellen E. Anderson Penno, M.D., M.S.
Gimbel Eye Centre
Calgary, Alberta, Canada
Kenneth J. Rosenthal, M.D., F.A.C.S.
Clinical Instructor
New York Medical College;
Private Practice
Kings Point, New York
Gary S. Schwartz, M.D.
Assistant Clinical Professor
Department of Ophthalmology
University of Minnesota
Stillwater, Minnesota
Barry Seibel, M.D.
Clinical Assistant Professor
University of California, Los Angeles;
Private Practice
Maloney–Seibel Vision Institute
Los Angeles, California
William E. Smiddy, M.D.
Professor
Department of Ophthalmology
University of Miami
Bascom Palmer Eye Institute
Miami, Florida
Roger F. Steinert, M.D.
Associate Clinical Professor
Department of Ophthalmology
Harvard Medical School
Ophthalmic Consultants of Boston
Boston, Massachusetts
Chapter 1
INJECTIBLE OPHTHALMIC
ANESTHESIA
Kenneth J. Rosenthal
Complications of regional anesthesia for ophthalmic surgery have become increasingly rare. This decreasing frequency can be attributed to awareness of anatomy and consequently better strategy for administering anesthetics, development of a safe and effective array of anesthetic substances, and the use of appropriate monitoring in the perioperative period. Nonetheless, while many anesthetic complications may be relatively innocuous, some may be sightor even life-threatening. As such, the administration of anesthesia should be done with proper training and experience and with care and respectful attention to detail.
GENERAL CONSIDERATIONS
In fact local anesthesia is the greatest single hazard in cataract surgery,1–4 accounting for adverse effects in 3.5% of patients (orbital adverse effects: 2.6%; systemic: 0.9%) according to a study by the Royal College of Ophthalmologists. The average cataract surgeon in the United States has a 3% chance each year of being sued over cataract surgery,5 and the majority of such cases relate to anesthetic complications such as globe perforations, inadvertent intraocular injections, and retinal detachment and intraocular hemorrhage associated with these misadventures.6
The purpose of anesthesia is to convert an otherwise painful, anxiety-producing, and unpleasant experience into a tolerable, comfortable, even pleasant and restful experience. In choosing an anesthetic technique, the least invasive, safest method, should always be employed. The extent, duration, and complexity of the surgery should therefore be evaluated in choosing
the route, duration, and depth of anesthesia employed. Exposure to anesthesia in excess of that which is necessary adds unnecessary risk to the procedure, and no tangible benefit to patient or surgical team. Regional anesthesia is usually preferable to general anesthesia, producing safer, equally effective, and cost-effi- cient results. However, just as it is inappropriate for a surgeon to use the same technique for every surgical intervention, it is equally wrong to use the same anesthetic for each case. While surgeons may subscribe to a particular philosophy of anesthesia for routine cases, it is important to assess each patient’s needs and act appropriately for exceptional cases.
DEFINITION OF INJECTIBLE BLOCK
Injectible techniques are anesthetic methods that involve the use of a sharp needle and an injectate; they include peribulbar as well as retrobulbar techniques, unless otherwise specified. The procedures collectively are referred to as “regional orbital anesthetic block.”7 It has been suggested that peribulbar block (also referred to as “periconal block”), involving injection outside of the muscle cone, entails less risk of complication than retrobulbar technique. However true this may be, complications have been observed with both techniques.8
PREOPERATIVE ASSESSMENT
Good planning is always part of the strategy to limit risk in anesthetic administration. If patients have preexisting systemic medical conditions, then some authors have felt that history, physical examination, 1
2 • COMPLICATIONS IN PHACOEMULSIFICATION
and laboratory testing should be performed.9 There is a great deal of regional and international variation in these requirements and no good standards have yet been established. A prospective multicenter clinical trial is evaluating this issue in 20,000 patients in the United States and Canada. The Study of Medical Testing for Cataract Surgery Randomized randomizes patients into either a no-routine-screening group or a routine-screening group; the latter group receives an electrocardiogram (EKG), electrolytes/ glucose, and a complete blood count (CBC). Demographic, clinical, and perioperative and medical event data is being collected through 7 days postsurgery to determine whether such testing results in differences in complications and outcomes between the two groups. A recent study by Rosenfeld et al,10 however, showed that the need for anesthesia intervention during cataract surgery was not correlated with the presence of heart disease, evidenced by an abnormal preoperative EKG, or with the presence of diabetes. EKGs and blood sugar are almost always performed during a preoperative evaluation. However, a history of systemic hypertension, pulmonary disease, renal disease, or cancer was associated with a statistically significant increase in incidence of intervention, suggesting that at least a review of the patient’s medical conditions is prudent in the immediate preoperative assessment.
Some investigators have shown that anesthetists did not make use of reported results of preoperative test and examinations, and that perioperative management was not influenced because of these investigations.11 Data from the National Survey of Local Anaesthesia for Ocular Surgery in 1997 reveals further that in patients who did not have any preoperative tests, there was a very low rate of serious adverse events that would have been influenced by such tests.12
Because cataract surgery is commonly performed on geriatric patients, a high incidence of systemic conditions such as diabetes, hypertension, coronary artery disease, obesity, chronic obstructive pulmonary disease, and arthritis may coexist and pose special challenges to the surgical and anesthesia teams. To limit the risks these conditions may generate, every effort should be made to ensure that the patient is optimally prepared for surgery. Nonetheless, cataract surgery can, in most instances, take place even in patients with these conditions.
During the immediate preoperative consultation, the patient should be asked to provide a list of current medications. In this way potential drug interactions can be anticipated, and it can be confirmed that the patient has appropriately taken the medications. It is helpful to schedule diabetic patients during the early morning, so that their oral hypoglycemics or insulin dosage can be taken immediately after the surgery. This minimally disrupts their usual routine. Alterna-
tively, they can be scheduled during the early afternoon so that they take their insulin and breakfast earlier in the day with sufficient time to fast prior to surgery.
CONSIDERATIONS REGARDING
ANTICOAGULATION
In general it is advisable to continue patients on systemic anticoagulants during routine cataract surgery, particularly in cases of small-incision phacoemulsification. Discontinuation of anticoagulant therapy may bear a greater risk than that of significant intraoperative ocular bleeding, even with retrobulbar injection.13 In these cases, however, it is of particular importance to use small needles and correct anatomic placement, and to avoid excessive manipulation while administering the injectible block. There are no studies to date, however, that have categorized the risk of cessation of anticoagulation as opposed to its continuance for many medical indications. It is recognized that stopping these medications has different implications for risk, depending on the underlying medical condition (e.g., atrial fibrillation vs. stroke vs. heart valve replacement). For example, a patient with mechanical heart valve replacement is at substantially higher risk for embolism or stroke than one with atrial fibrillation as the underlying reason for treatment. These factors should be weighed carefully, in consultation with the patient’s internist, to determine the systemic and ocular risks in each case.
THE ROLE OF THE ANESTHESIA
CAREGIVER
In the United States, both CRNAs (certified registered nurse anesthetists) and physician (MD or OD) anesthesiologists have been trained to administer anesthetics, monitor and treat a patient’s systemic condition, and provide suitable sedation. Although there are regional variations in the usage of anesthesia services both through the United States and internationally,14 the role of this vital team member cannot be overlooked. In an era where cost containment has reached a high degree of awareness, it is important to evaluate the necessity of each aspect of the care we provide. Rosenfeld et al10 showed that during cataract surgery, major anesthesia intervention (i.e., more than just verbal reassurance, hand holding, or physical restraint) was required in 28.6% of all patients. While intervention was required more often in patients with certain underlying diseases, almost a third of patients without predisposing factors required intervention of some type. This sug-
CHAPTER 1 INJECTIBLE OPHTHALMIC ANESTHESIA • 3
gests that with current methods it is impossible to predict preoperatively which patients will require intervention, thereby suggesting further that, to avoid perioperative complications, anesthesia monitoring is essential in all patients undergoing cataract surgery.
SEDATION AND MONITORING
Considerable debate has persisted regarding the usefulness of intravenous (IV) sedation for cataract surgery, particularly with the use of topical anesthetic agents and minimally invasive surgical technique. Although the specifics of this debate are outside the realm of this discussion, it is important to understand what constitutes appropriate use of this mode of treatment.
The anesthesiologist must possess appropriate personality traits and communication skills to enable them to gain patient trust and confidence.15 Additionally, the practitioner should educate the patient about the forthcoming experience. This helps to reduce the patient’s anxiety and decrease perioperative complications.16
Perioperative monitoring should consist, at a minimum, of EKG, pulse oximetry, and periodic blood pressure measurement.17,18 The latter should be kept to a minimum during critical surgical periods so as not to increase patient discomfort, anxiety, or movement during surgery.
The goal of IV sedation is to alleviate anxiety, while allowing the patient to remain stationary, calm, comfortable, and cooperative. In regard to the absolute amount of anesthetic agent given and the level of consciousness attained, elderly patients generally require less pharmacologic limitation of anxiety during surgery than do younger patients. It is essential to produce anxiolysis without obtundation. The latter may result in a patient who is periodically and unpredictably combative,19–22 and may cause further depression of preexisting cardiac and respiratory instabilities.23–27 In an effort to prevent this situation, excessive IV sedation should never be used to compensate for an incomplete regional anesthetic block. Rather, the incomplete regional block should be managed by supplementation of the local anesthesia. To do otherwise will subject the patient to an unpleasant, stressful, and potentially dangerous experience.15
COMPLICATIONS OF PHARMACOLOGIC
AGENTS
Systemic toxicity of anesthetic agents is usually associated with (1) inadvertent ectopic injection of an
agent, (2) overdose of a particular agent, (3) allergic reactions, or (4) vasovagal responses.
Ectopic injection may be propagated by the intravascular route or through inadvertent direct central nervous system injection through the subdural route via penetration of the optic nerve sheath.
These will each be discussed in their respective sections. However, as a general measure, limitation of these problems can be accomplished by (1) gentle preinjection aspiration to ensure an extravascular location of the needle, and (2) slow and patient injection of anesthetics15 (no more than 2 cc/min) while monitoring the patient for any signs of systemic toxicity. Finally, the use of hyaluronidase may be associated with allergic or frankly anaphylactic reactions.28 Therefore, this proteolytic drug should be avoided in atopic individuals. A study by Prosser et al29 suggests that hyaluronidase may not be necessary, at least in peribulbar blocks.
TECHNIQUE OF RETRO/PERIBULBAR
INJECTION
In preparation for the administration of the injection, the surgeon must have an awareness of the axial length of the surgical eye. A preexamination of the orbit/globe relationship should be done, and proper instruction to the patient should be given so as to avoid unnecessary movement. A history of prior difficulties with regional block in the companion eye should also be investigated and etiologic factors delineated before proceeding with the second eye.
Techniques that may reduce the likelihood of perforation have been described by numerous authors. Current practice consists of a sharp needle technique with insertion either at or slightly below the lateral canthus, or, alternatively, at the medial canthus. The needle is placed preferably though the conjunctiva rather than through the lid. The eye should be held open, remain in primary gaze, and be observed throughout the needle insertion and anesthetic injection. The eye should not move during this maneuver, as this may indicate that the sclera has been engaged. The classic concept of looking “up and in,” as popularized by Atkinson, should be absolutely avoided because it brings the optic nerve closer to the inferotemporal quadrant and places it on stretch, making it more susceptible to injury (Fig. 1–1).
There is still debate about the ideal needle for this task. Some authors, such as Waller et al, recommend using a dull needle, stating that a theoretically greater force would be required to penetrate the sclera. This argument, however, fails when one considers that any needle sharp enough to penetrate the skin will probably encounter little difficulty in penetrating the sclera. Further, because eyes at high risk for perforation often
4 • COMPLICATIONS IN PHACOEMULSIFICATION
FIGURE 1–1 Optic nerve damage. When eye is positioned “up and in,” as has been the classic teaching, the nerve is placed on stretch and positioned more inferiorly and temporally. This increases the risk of nerve damage during injection.
have scleral ectasia, there would be sufficient thinning to allow even a dull needle to penetrate. I prefer a straight, sharp, 27-gauge, short (no longer than 31 mm) bevel needle inserted as described above, with the bevel toward the globe, thus reducing the risk of damage to critical structures.
A medial orbital injection is also occasionally utilized. In this technique the needle is placed at the caruncle and injection is administered with the needle positioned with the bevel facing away from the globe so as to accommodate the sharply medioposterior sloping of the medial orbital wall (Fig. 1–2).
FIGURE 1–2 Medial block. A 27-gauge, 20to 25-mm sharp needle is placed at the caruncle with the bevel pointed away from the globe. When the needle hub reaches the plane of the iris, the anesthetic is injected near the medial orbital wall.
In retrobulbar anesthesia, the needle is inserted inferiorally, one-third the way from the lateral canthus. It is then advanced along the orbital floor. Immediately on perforating the skin or conjunctivae, the globe is actually pushed superiorally with digital pressure. Once the needle is well past the equator, it is slightly withdrawn and redirected superiorally at an approximately 15-degree angle. The needle can be felt to “pop” through the muscle cone, and the anesthetic volume is delivered with a slow and steady injection, with attention to any unusual resistance (Fig. 1–3).
With peribulbar anesthesia the needle is inserted similarly, but never redirected into the muscle cone. Instead, the anesthetic is delivered near the orbital rim. Generally it is necessary to wait a longer period of time after a peribulbar block for adequate anesthetic effect. Peribulbar injection is particularly useful superotemporally to provide sensory and motor anesthesia to the superior orbit and lid (Fig. 1–4).
PENETRATION AND PERFORATION
OF THE GLOBE
The administration of regional orbital anesthetic block is a technique requiring specific training and experience. In some institutions the block is given by the least experienced surgeon or by anesthesia personnel who often have inadequate experience or training. This practice is to be discouraged. A detailed study of the orbit, its nerves, vasculature, and soft tissue septa should be undertaken prior to undertaking injectible anesthesia. Regional orbital anesthesia requires an anatomic appreciation in three dimensions. To ensure success, hands-on, one-to-one training is required.
Globe penetration is the most common of the serious complications of injectible anesthesia and has been documented by numerous authors.30–33 Globe perforation and inadvertent intraocular injections also rank as two of the most common causes of litigation after cataract surgery.6 Ocular penetration refers to the entry of a needle into the globe after which the needle is withdrawn. Ocular perforation suggests that the needle entered the eye and then exited through another part of the globe prior to having been withdrawn. Because the clinical pictures are similar, the terms are used interchangeably in this discussion.
The actual incidence of ocular penetration is difficult to determine. This is due to a tremendous diversity of reports that have appeared in the literature. Reported incidences range from as few as one penetration in 16,224 consecutive cases,34,35 to as many as 1 in 100 cases. Teichmann and Uthoff36 reported an incidence of 0 in 21,000 using their technique. If the incidences reported in several available references
CHAPTER 1 INJECTIBLE OPHTHALMIC ANESTHESIA • 5
FIGURE 1–3 Inferotemporal block. The eye is held in primary gaze. The eye is digitally elevated and the injection is performed through the conjunctivae. (A) The needle passes posteriorally at a 10 to 15-degree elevation from the coronal plane until the equator is reached. (B) The needle is then advanced slowly, dropping the hub as it passes over the orbital floor. (C) The needle hub, now behind the equator, is depressed and the tip is advanced through the muscle cone.
are averaged, the occurrence rate is approximately 0.01%.
Because the risk of this complication is directly related to the number of injections given, every effort should be made to reduce the frequency of multiple injections. Correct needle placement, use of hyaluronidase, and adequate volume of injectate will increase the likelihood of success of a “first take.” Ocular compression devices such as the “superpinky” or the Honan’s37–39 balloon may likewise improve the
distribution of anesthetic. They must be used judiciously to avoid both vascular compromise to the globe and the creation of an excessively soft eye. A good end point for determination of adequate block should be the ablation of sensation to the area to be operated upon. Testing by lightly pinching the conjunctiva with a 0.12 Castroviejo forceps will give adequate indication of anesthesia. It is not necessary to achieve akinesia or amaurosis. Insistence on achieving these end points may result in the necessity of
FIGURE 1–4 Superotemporal peribulbar block. The globe is manually depressed with digital pressure. The needle is directed through the lid 3 mm lateral to the lateral limbus and aimed toward the roof of the orbit. The needle is advanced until it is just posterior to the equator. The injection is then performed.
